Mariah
Rivera

Secured a complete defense arbitration award after a two-week trial for the country’s largest integrated health care system against claims that it improperly withheld tens of millions of dollars in payments from a hospital system. The arbitrator rejected the hospitals’ breach of contract, breach of implied covenant, declaratory judgment, and California unfair competition claims by adopting our arguments that the health care system’s line-item denials were within the scope of its broad contractual rights to review and audit the hospitals’ billed claims before payment.

Representing the major record labels, including UMG Recordings, Warner Music Group and Sony Music Entertainment, in high-profile, high-stakes copyright litigation against two leading generative AI music companies, Suno and Udio. The lawsuits are the first time the record labels have sued AI companies over sound recording copyrights (see “AI Cos. Hit With Copyright Claims From Music Labels,” Law360; “Major record labels sue AI company behind ‘BBL Drizzy,’” The Verge; “Music Labels Take On AI Startups With New Lawsuits,” The Wall Street Journal; “AI’s Most Ambitious Music Generators Accused of ‘Massive’ Infringement In New Lawsuit,” Rolling Stone).

Representing AbbVie, a defendant in the multibillion-dollar Allergan textured breast implant litigation, which involves approximately 1,700 individual lawsuits and a nationwide class action in four venues including multidistrict litigation in the District of New Jersey. The plaintiffs contend AbbVie’s BIOCELL® textured breast implants cause a rare type of cancer, and they argue AbbVie is liable under manufacturing defect, failure to warn, and misrepresentation theories.

Successfully reached a settlement on behalf of a portfolio company in a breach of contract lawsuit against a major alcohol beverage company.